Target intelligence / Profile preview

Heme (Iron-protoporphyrin IX) (Heme)

Target
Heme
Molecular classification
Prosthetic group, Porphyrin, Metalloprotein component, Iron-binding cofactor
01

Overview

Heme is a coordination complex consisting of an iron ion coordinated to a protoporphyrin IX ring, serving as the essential prosthetic group for hemoproteins like hemoglobin and myoglobin (StatPearls, 2023). In hemoglobin, heme facilitates the reversible binding and transport of oxygen from the lungs to tissues, while in myoglobin, it provides an oxygen reserve for muscle fibers (NIH, 2022). Heme is a critical therapeutic target in malaria treatment; Plasmodium parasites digest host hemoglobin, releasing toxic free heme which they must neutralize into hemozoin crystals. Antimalarial drugs such as chloroquine and quinine work by inhibiting this crystallization process, leading to the accumulation of toxic heme and subsequent parasite death (PubMed, 2021). Additionally, heme is the site of toxicity for carbon monoxide and cyanide, which bind to the iron center with significantly higher affinity than oxygen, thereby inhibiting cellular respiration and oxygen delivery (CDC, 2022).

Other names
Ferriprotoporphyrin IXHeminHematinIron-protoporphyrin IXHeme b
02

Mechanism of action

Inhibition of heme biocrystallization into hemozoin; competitive binding to the ferrous or ferric iron center; induction of oxidative stress through free heme accumulation (PubMed, 2021; StatPearls, 2023).

03

Biological functions

Oxygen transportOxygen storageElectron transferCellular respirationCatalysis
04

Disease associations

MalariaCarbon monoxide poisoningCyanide poisoningMethemoglobinemiaSickle cell diseaseThalassemiaPorphyria
05

Safety considerations

Oxidative stress and lipid peroxidation (PubMed, 2019)Pro-inflammatory effects of free heme (NIH, 2020)Potential for hemolysis in G6PD deficient patients when using certain heme-interacting drugs (StatPearls, 2023)
06

Interacting drugs

Chloroquine

8 more in the full profile.

07

Biomarkers

Total hemoglobin concentration (StatPearls, 2023)Methemoglobin percentage (NIH, 2022)Carboxyhemoglobin levels (CDC, 2022)Plasma free hemoglobin/heme (PubMed, 2020)

Beyond the preview

Go deeper on Heme (Iron-protoporphyrin IX) (Heme).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heme (Iron-protoporphyrin IX) (Heme).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call